review will assess the article: ‘Panax ginseng C.A Meyer root extract for
moderate Chronic Obstructive Pulmonary Disease (COPD): study protocol for a
randomised controlled trial’, published in 2012 by Xue et al. in the E-journal,
Trials, volume 12 number 164. The assessment will focus on the knowledge
contribution of the article to the field of translational medicine and evidence
based research for use of Complementary and Alternative Medicine (CAM).
medicine, a research dissemination tool for advancing gains of basic laboratory
discoveries to populations via clinical studies, has come to be a very useful
tool for the practice of conventional medicines. This paradigm has also found
usefulness as an emerging trend in the development and practice of CAM. CAM,
though older than conventional medicine, have found rebirth in the healing
sphere owing to public demand and based on successful psychometric evaluations
using various rigorous study designs of Randomised Controlled Trials (RCT).
The goal of
designing a study protocols is to obtain a tool for measuring and evaluating
how an intervention, medical device or diagnostic contribute to improvement in
health status or knowledge. Hence, this review will assess the scientific
rigour and proof of principles demonstrated by the author in developing the
study design. The article will be summarised, assessed on presentation
effectiveness and the depth of literature on current knowledge. A critique on
authority, currency, relevance, accuracy, objectivity and stability will be
carried out and the conclusion will present the statement of scientific value
of the article.
[1.] Brownson, R. C., Kreuter, M. W., Arrington, B. A.,
& True, W. R., (2006). Translating Scientific Discoveries Into Public
Health Action: How Can Schools Of Public Health Move Us Forward? Public Health
Reports Volume 121, 97-103
[2.] Elder, C., Aickin, M., Bauer, V., Cairns, J., &
Vuckovic, N., (2006). Randomized trial of a whole-system ayurvedic protocol for
type 2 diabetes. Altern Ther Health Med. 12(5), 24-30.
[3.] Ernst, E., Cohen, M. H., & Stone, J., (2004).
Ethical problems arising in evidence based complementary and alternative
medicine. J Med Ethics, 30, 156–159. doi: 10.1136/jme.2003.007021
[4.] Ferrer, M., Alonso, J., Morera, J., Marrades, R. M.,
Khalaf, A., Aguar, M. C., Plaza, V., Prieto, L., & Antó, J. M., (1997).
Chronic obstructive pulmonary disease stage and health-related quality of life.
The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann
Intern Med. 127(12), 1072-1079.
[5.] Frenkel, M. A., & Borkan J. M., (2003). An
approach for integrating complemetary–alternative medicine into primary care.
Family Practice, 20(3), 324–332. Doi: 10.1093/fampra/cmg315, available online
[6.] Gross, D., Shenkman, Z., Bleiberg, B., Dayan, M.,
Gittelson, M., & Efrat, R., (2002). Ginseng improves pulmonary functions
and exercise capacity in patients with COPD. Monaldi Arch Chest Dis. 57(5-6),
[7.] Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav,
E., Buist, A. S., & Mannino, D. M., ( 2006). Global burden of COPD:
systematic review and meta-analysis. Eur Respir J. 28(3), 523-532.
[8.] Ludbrook, J., (2000). Multiple inferences using
confidence intervals. Clin Exp Pharmacol Physiol. 27(3), 212-215.
[9.] Price, D., Freeman, D., Cleland, J., Kaplan, A., &
Cerasoli, F., (2011). Earlier diagnosis and earlier treatment of COPD in
primary care. Prim Care Respir J. 20(1), 15-22. doi: 10.4104/pcrj.2010.00060.
[10.] Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J.,
Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R.,
van Weel, C., & Zielinski, J.,(2007). Global strategy for the diagnosis,
management, and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med. 176(6), 532-555.
[11.] Shergis, J. L., Parker, S., Coyle, M. E., Zhang, A.
L., & Xue C. C., (2013), ‘Key considerations for conducting Chinese
medicine clinical trials in hospitals’. Chinese Medicine vol. 8, no. 3
[12.] Sun, X. G., Lin, D., Wu, W., & Lv,. Z.(2011).
Translational Chinese Medicine: A Way for Development of Traditional Chinese
Medicine. Chinese Medicine, 2, 186-190 doi:10.4236/cm.2011.24029.
[13.] Terzic A., & Waldman S. A., (2010) Translational
medicine: path to personalized and public health Biomarkers Med. 4(6), 787–790.
[14.] Verhoef, M. J., Vanderheyden, L. C., Dryden,T.,
Mallory, D., & Ware M. A., (2006). Evaluating complementary and alternative
medicine interventions: in search of appropriate patient-centered outcome
measures. BMC Complementary and Alternative Medicine, 6(38)
[15.] Waldman S. A., & Terzic A., (2009). Translational
medicine in the era of health care reform. Clin. Transl. Sci. 2, 96–97.
[16.] Walker, L. G. & Anderson, J., (1999). Testing
complementary and alternative therapies within a research protocol. Eur J